Effectiveness of a Multimodal Therapeutic Approach for Disorganization Symptoms in Hebephrenic Schizophrenia: A Case Report
Authors:
Open Access
- 7 November 2025
- journal article
- Published by PT. Penerbit Ilmiah Indonesia in Psychosocia : Journal of Applied Psychology and Social Psychology
- Vol. 4 (1) , 1-13
Abstract
Hebephrenic schizophrenia, or disorganized-type schizophrenia, represents one of the most disabling and treatment-resistant subtypes of psychotic disorders, marked by disorganized thinking, affect, and behavior. These symptoms often persist despite standard pharmacological treatment and are associated with poor cognitive and social functioning. This case report explores the effectiveness of an integrated multimodal therapeutic approach that combines pharmacological, cognitive-behavioral, and metabolic strategies in managing a young woman with chronic hebephrenic schizophrenia. The patient, a 23-year-old female with a six-year illness duration and history of medication nonadherence, was treated with aripiprazole 15 mg/day (dopamine D2 partial agonist), trifluoperazine 5 mg/day (full D2 antagonist), folic acid 1 mg/day, and vitamin B6 100 mg/day. Cognitive Behavioral Therapy (CBT) and family psychoeducation were conducted twice weekly for three weeks. After treatment, she demonstrated measurable improvement, including a 1-point reduction in conceptual disorganization and a 2-point improvement in blunted affect (PANSS-R), alongside qualitative gains in coping with auditory hallucinations and affective responsiveness. These results suggest that synergistic modulation of dopaminergic circuits, cognitive restructuring, and metabolic support may yield short-term benefits for patients with treatment-resistant disorganization symptoms. Further longitudinal studies are warranted to evaluate long-term outcomes and neurobiological mechanisms.Keywords
This publication has 22 references indexed in Scilit:
- Whether serum leptin and insulin-like growth factor-1 are predictive biomarkers for post-stroke depression: A meta-analysis and systematic reviewJournal of Psychiatric Research, 2023
- Consensus design of a calibration experiment for human fear conditioningNeuroscience & Biobehavioral Reviews, 2023
- Corrigendum to “Brave New World: Harnessing the promise of biomarkers to help solve the epigenetic puzzle” [Schizophr. Res. 242 (2022) 35–41]Schizophrenia Research, 2022
- Predictors of complete recovery of oculomotor nerve palsy induced by posterior communicating artery aneurysms in patients aged eighteen to sixtyJournal of Clinical Neuroscience, 2022
- Patients with schizophrenia are under‐vaccinated for COVID‐19: a report from IsraelWorld Psychiatry, 2021
- Are basic auditory processes involved in source-monitoring deficits in patients with schizophrenia?Schizophrenia Research, 2019
- Complex mismatch negativity to tone pair deviants in long-term schizophrenia and in the first-episode schizophrenia spectrumSchizophrenia Research, 2018
- Religious Coping and Cancer: Proposing an Acceptance and Commitment Therapy ApproachCognitive and Behavioral Practice, 2010
- Olfactory ensheathing glia and Schwann cells exhibit a distinct interaction behavior with meningeal cellsJournal of Neuroscience Research, 2009
- World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophreniaSchizophrenia Research, 2008